🇺🇸 Zirconium Cyclosilicate in United States

469 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 469

Most-reported reactions

1. Death — 252 reports (53.73%)
2. Blood Potassium Increased — 32 reports (6.82%)
3. Acute Kidney Injury — 26 reports (5.54%)
4. Vomiting — 26 reports (5.54%)
5. Hyperkalaemia — 24 reports (5.12%)
6. Chronic Kidney Disease — 23 reports (4.9%)
7. Renal Failure — 23 reports (4.9%)
8. Pneumonia — 22 reports (4.69%)
9. End Stage Renal Disease — 21 reports (4.48%)
10. Off Label Use — 20 reports (4.26%)

Source database →

Frequently asked questions

Is Zirconium Cyclosilicate approved in United States?

Zirconium Cyclosilicate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Zirconium Cyclosilicate in United States?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.